C07D 498/14
Ortho-condensed systems
C07D498/14 (Ortho-condensed systems) appears on 631 US grants and 942 published applications in this corpus.
Search patents in C07D- Granted patents
- 631
- Published applications
- 942
- Assignees
- 423
- Inventors
- 2,617
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 1 |
| 2003 | 1 | 2 |
| 2004 | 1 | 6 |
| 2005 | 0 | 7 |
| 2006 | 4 | 16 |
| 2007 | 6 | 17 |
| 2008 | 8 | 6 |
| 2009 | 9 | 19 |
| 2010 | 11 | 27 |
| 2011 | 11 | 29 |
| 2012 | 21 | 34 |
| 2013 | 32 | 31 |
| 2014 | 37 | 57 |
| 2015 | 52 | 58 |
| 2016 | 47 | 49 |
| 2017 | 47 | 67 |
| 2018 | 43 | 60 |
| 2019 | 45 | 46 |
| 2020 | 45 | 57 |
| 2021 | 39 | 60 |
| 2022 | 41 | 54 |
| 2023 | 21 | 63 |
| 2024 | 38 | 73 |
| 2025 | 23 | 53 |
| 2026 | 28 | 50 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Substituted macrocyclic compounds and related methods of treatment6 Oct 2026US 12,753,188 B2Alkermes, Inc.
- Fibroblast activation protein ligands for targeted delivery applications29 Sep 2026US 12,747,224 B2Philochem AG
- EIF4A-inhibiting compounds and methods related thereto29 Sep 2026US 12,747,249 B2SJP Biotec GmbH
- Compounds useful as immunomodulators25 Aug 2026US 12,715,856 B2Bristol-Myers Squibb Company
- Tricyclic pyrimidines as cyclin-dependent kinase 7 (CDK7) inhibitors25 Aug 2026US 12,715,878 B2Janssen Pharmaceutica NV
- Hexahydro[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine deuterated derivative, pharmaceutical composition thereof, preparation method therefor, and anti-influenza use thereof8 Oct 2026US 2026/0308174 A1Changsha Jingyi Pharmaceutical Technology Co., Ltd
- Kif18a inhibitor compound, and pharmaceutical composition and preparation method therefor and use thereof1 Oct 2026US 2026/0294927 A1Changchun Genescience Pharmaceutical Co., Ltd.
- Acyl Ethyl Ester Polycyclic Compound, and Pharmaceutical Composition and Use Thereof17 Sep 2026US 2026/0272943 A1Nanjing Cavendish Bio-Engineering Technology Co., Ltd.
- Composition and Method for Treating Metabolic Disorders17 Sep 2026US 2026/0274834 A1VeroScience LLC
- Cereblon Ligands and Uses Thereof10 Sep 2026US 2026/0265271 A1Oncopia Therapeutics, Inc. d/b/a SK Life Science Labs
Most cited
By later US patents
- Intermediates useful for making 2,4-pyrimidinediamine compounds192US 7,060,827 B2Rigel Pharmaceuticals, Inc. · 2006
- 2,4-pyrimidinediamine compounds and their uses176US 7,557,210 B2Rigel Pharmaceuticals, Inc. · 2009
- Matansinol 3-n-hexadecanoate144US 4,265,814 ATakeda Chemical Industries, Ltd. · 1981
- 2,4-pyrimidinediamine compounds and their uses119US 7,329,671 B2Rigel Pharmaceuticals, Inc. · 2008
- 2,4-pyrimidinediamine compounds and their uses114US 7,332,484 B2Rigel Pharmaceuticals, Inc. · 2008